Literature DB >> 169640

Serologic studies of acute respiratory infections in military personnel.

A S Evans.   

Abstract

The advantages, disadvantages, and uses of serological epidemiology are discussed in relation to acute respiratory infections in military personnel. The prevalence of antibody reflects both current and past experience with respiratory agents and is a measure of susceptinility. Incidence data calculated by testing two serial serum samples, on entry and discharge from the service, has indicated high influenza and mycoplasma pneumoniae rates in South American recruits and low rates of adenovirus and parainfluenza infections. Serologic analysis of reinfection rates showed high protection against influenza infections at HI antibody levels of over 1:40, against adenovirus infections at neutralizing titers of 1:5, and against M. pneumoniae infections at TRI antibody levels over 1:8. Antibody responses persisting at least 7 mo following immunization were demonstrated in 70% of 428 vaccinated young adults for A2 antigen and 20% for influenza B antigen. No relation of ABO blood groups to respiratory infection was found. The lack of myxovirus infections in four Polaris submarines is presented.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169640      PMCID: PMC2595222     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  16 in total

1.  A health and seroepidemiological survey of a community in Barbados.

Authors:  A Evans; F Cox; G Nankervis; E Opton; R Shope; A V Wells; B West
Journal:  Int J Epidemiol       Date:  1974-06       Impact factor: 7.196

2.  Prospective studies of a group of Yale University freshmen. II. Occurrence of acute respiratory infections and rubella.

Authors:  A S Evans; J C Niederman; R N Sawyer
Journal:  J Infect Dis       Date:  1971-03       Impact factor: 5.226

3.  Prospective studies of a group of Yale University freshmen. I. Occurrence of infectious mononucleosis.

Authors:  R N Sawyer; A S Evans; J C Niederman; R W McCollum
Journal:  J Infect Dis       Date:  1971-03       Impact factor: 5.226

4.  Seroepidemiologic studies of infectious mononucleosis with EB virus.

Authors:  A S Evans; J C Niederman; R W McCollum
Journal:  N Engl J Med       Date:  1968-11-21       Impact factor: 91.245

5.  A nationwide serum survey of Argentinian military recruits, 1965-1966. I. Description of sample and antibody patterns with arboviruses, polioviruses, respiratory viruses, tetanus and treponematosis.

Authors:  A S Evans; J Casals; E M Opton; E K Borman; L Levine; R Cuadrado
Journal:  Am J Epidemiol       Date:  1971-02       Impact factor: 4.897

6.  Hong Kong influenza: the epidemiologic features of a high school family study analyzed and compared with a similar study during the 1957 Asian influenza epidemic.

Authors:  L E Davis; G G Caldwell; R E Lynch; R E Bailey; T D Chin
Journal:  Am J Epidemiol       Date:  1970-10       Impact factor: 4.897

7.  Infectious mononucleosis in the Armed Forces.

Authors:  A S Evans
Journal:  Mil Med       Date:  1970-04       Impact factor: 1.437

8.  The Tecumseh study of respiratory illness. VII. Further observations on the occurrence of respiratory syncytial virus and Mycoplasma pneumoniae infections.

Authors:  A S Monto; E R Bryan; L M Rhodes
Journal:  Am J Epidemiol       Date:  1974-12       Impact factor: 4.897

9.  Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years.

Authors:  T J Hallee; A S Evans; J C Niederman; C M Brooks; j H Voegtly
Journal:  Yale J Biol Med       Date:  1974-09

10.  ABO blood groups and viral diseases.

Authors:  A S Evans; D A Shepard; V A Richards
Journal:  Yale J Biol Med       Date:  1972-04
View more
  10 in total

1.  A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes.

Authors:  Laurent Coudeville; Philippe Andre; Fabrice Bailleux; Françoise Weber; Stanley Plotkin
Journal:  Hum Vaccin       Date:  2010-10-01

2.  MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020).

Authors:  Barbara C Baudner; Vanessa Ronconi; Daniele Casini; Marco Tortoli; Jina Kazzaz; Manmohan Singh; Lynn D Hawkins; Andreas Wack; Derek T O'Hagan
Journal:  Pharm Res       Date:  2009-03-03       Impact factor: 4.200

3.  Two adenovirus serotype 3 outbreaks associated with febrile respiratory disease and pharyngoconjunctival fever in children under 15 years of age in Hangzhou, China, during 2011.

Authors:  Li Xie; Xin-Fen Yu; Zhou Sun; Xu-Hui Yang; Ren-Jie Huang; Jing Wang; Apeng Yu; Lin Zheng; Man-Chu Yu; Xiao-Wei Hu; Ban-Ma Wang; Jin Chen; Jing-Cao Pan; She-Lan Liu
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

4.  Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model.

Authors:  Laurent Coudeville; Fabrice Bailleux; Benjamin Riche; Françoise Megas; Philippe Andre; René Ecochard
Journal:  BMC Med Res Methodol       Date:  2010-03-08       Impact factor: 4.615

5.  Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus.

Authors:  Victor C Huber; Loren H Kleimeyer; Jonathan A McCullers
Journal:  Vaccine       Date:  2008-08-15       Impact factor: 3.641

6.  Influenza infection rates, measurement errors and the interpretation of paired serology.

Authors:  Simon Cauchemez; Peter Horby; Annette Fox; Le Quynh Mai; Le Thi Thanh; Pham Quang Thai; Le Nguyen Minh Hoa; Nguyen Tran Hien; Neil M Ferguson
Journal:  PLoS Pathog       Date:  2012-12-13       Impact factor: 6.823

7.  Immunization against swine influenza in the Yale University Community.

Authors:  A S Evans; G Kraus
Journal:  Yale J Biol Med       Date:  1978 Mar-Apr

8.  HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy.

Authors:  Peter B Gilbert; Youyi Fong; Michal Juraska; Lindsay N Carpp; Arnold S Monto; Emily T Martin; Joshua G Petrie
Journal:  BMC Infect Dis       Date:  2019-05-22       Impact factor: 3.090

9.  Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection.

Authors:  Annette Fox; Le Quynh Mai; Le Thi Thanh; Marcel Wolbers; Nguyen Le Khanh Hang; Pham Quang Thai; Nguyen Thi Thu Yen; Le Nguyen Minh Hoa; Juliet E Bryant; Tran Nhu Duong; Dang Dinh Thoang; Ian G Barr; Heiman Wertheim; Jeremy Farrar; Nguyen Tran Hien; Peter Horby
Journal:  J Infect       Date:  2014-09-16       Impact factor: 6.072

10.  Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.

Authors:  Larisa Rudenko; Irina Kiseleva; Elena Krutikova; Ekaterina Stepanova; Andrey Rekstin; Svetlana Donina; Maria Pisareva; Elena Grigorieva; Kirill Kryshen; Arman Muzhikyan; Marina Makarova; Erin Grace Sparrow; Guido Torelli; Marie-Paule Kieny
Journal:  PLoS One       Date:  2018-12-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.